Analysing stratified medicine business models and value systems: innovation-regulation interactions.

Abstract

Stratified medicine offers both opportunities and challenges to the conventional business models that drive pharmaceutical R&D. Given the increasingly unsustainable blockbuster model of drug development, due in part to maturing product pipelines, alongside increasing demands from regulators, healthcare providers and patients for higher standards of safety… (More)
DOI: 10.1016/j.nbt.2012.03.003

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.